Search
Displaying results 1 - 10 of 21 in total
Everolimus
go.drugbank.com/drugs/DB01590
ApprovedInvestigational
Everolimus is a derivative of Rapamycin (sirolimus), and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor. It is currently used as an immunosuppressant to prevent rejection of organ transplants. In a similar fashion to other mTOR inhibitors Everolimus' effect is solely on the mTORC1 ...
Tuberous Sclerosis Complex with Subependymal Giant Cell Astrocytoma
go.drugbank.com/conditions/DBCOND0025535Drugs: EverolimusLocally advanced Progressive Neuroendocrine Tumors of gastrointestinal origin
go.drugbank.com/conditions/DBCOND0025527Drugs: EverolimusMetastatic gastrointestinal origin Progressive Neuroendocrine Tumors
go.drugbank.com/conditions/DBCOND0093542Drugs: EverolimusProgressive Neuroendocrine Tumors of pancreatic origin
go.drugbank.com/conditions/DBCOND0025525Drugs: EverolimusTuberous Sclerosis Complex with Renal angiomyolipoma
go.drugbank.com/conditions/DBCOND0025534Drugs: EverolimusLocally advanced lung origin Progressive Neuroendocrine Tumors
go.drugbank.com/conditions/DBCOND0093546Drugs: Everolimus